Moustafa E. El-Araby, Ph.D. - Publications

Affiliations: 
2001 State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Pharmaceutical Chemistry, Organic Chemistry

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Muhammad YA, Omar AM, Ahmed F, Khayat MT, Malebari AM, Ibrahim SM, Mass SA, Elfaky MA, El-Araby ME. Exploring antiproliferative activities and kinase profile of ortho-substituted N-(4-(2-(benzylamino)-2-oxoethyl)phenyl)benzamides. Chemical Biology & Drug Design. PMID 37873688 DOI: 10.1111/cbdd.14379  0.436
2023 Omar AM, Abdulmalik O, El-Say KM, Ghatge MS, Cyril-Olutayo M, Paredes S, Al-Awadh M, El-Araby ME, Safo MK. Targeted modification of furan-2-carboxaldehydes into Michael acceptor analogs yielded long-acting hemoglobin modulators with dual antisickling activities. Chemical Biology & Drug Design. PMID 37798397 DOI: 10.1111/cbdd.14371  0.433
2022 Khayat MT, Omar AM, Ahmed F, Khan MI, Ibrahim SM, Muhammad YA, Malebari AM, Neamatallah T, El-Araby ME. Insights on Cancer Cell Inhibition, Subcellular Activities, and Kinase Profile of Phenylacetamides Pending 1-Imidazol-5-One Variants. Frontiers in Pharmacology. 12: 794325. PMID 35069208 DOI: 10.3389/fphar.2021.794325  0.45
2020 Omar AM, Abdulmalik O, Ghatge MS, Muhammad YA, Paredes SD, El-Araby ME, Safo MK. An Investigation of Structure-Activity Relationships of Azolylacryloyl Derivatives Yielded Potent and Long-Acting Hemoglobin Modulators for Reversing Erythrocyte Sickling. Biomolecules. 10. PMID 33147875 DOI: 10.3390/biom10111508  0.422
2020 Omar AM, Bajorath J, Ihmaid S, Mohamed HM, El-Agrody AM, Mora A, El-Araby ME, Ahmed HEA. Novel molecular discovery of promising amidine-based thiazole analogues as potent dual Matrix Metalloproteinase-2 and 9 inhibitors: Anticancer activity data with prominent cell cycle arrest and DNA fragmentation analysis effects. Bioorganic Chemistry. 101: 103992. PMID 32554279 DOI: 10.1016/J.Bioorg.2020.103992  0.432
2020 Elfaky MA, El-Halawany AM, Koshak AE, Alshali KZ, El-Araby ME, Khayat MT, Abdallah HM. Bioassay Guided Isolation and Docking Studies of a Potential β-Lactamase Inhibitor from . Molecules (Basel, Switzerland). 25. PMID 32486455 DOI: 10.3390/Molecules25112566  0.481
2020 Omar AM, El-Araby ME, Abdelghany TM, Safo MK, Ahmed MH, Boothello R, Patel BB, Abdel-Bakky MS, Malebari AM, Ahmed HEA, Elhaggar RS. Introducing of potent cytotoxic novel 2-(aroylamino)cinnamamide derivatives against colon cancer mediated by dual apoptotic signal activation and oxidative stress. Bioorganic Chemistry. 101: 103953. PMID 32474179 DOI: 10.1016/J.Bioorg.2020.103953  0.5
2020 Omar AM, Elfaky MA, Arold ST, Soror SH, Khayat MT, Asfour HZ, Bamane FH, El-Araby ME. 1-Imidazole-2,5-Dicarboxamides as NS4A Peptidomimetics: Identification of a New Approach to Inhibit HCV-NS3 Protease. Biomolecules. 10. PMID 32245218 DOI: 10.3390/biom10030479  0.347
2019 Omar AM, David T, Pagare PP, Ghatge MS, Chen Q, Mehta A, Zhang Y, Abdulmalik O, Naghi AH, El-Araby ME, Safo MK. Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agents. Medchemcomm. 10: 1900-1906. PMID 32206236 DOI: 10.1039/C9Md00291J  0.432
2018 Omar AM, Abdelghany TM, Abdel-Bakky MS, Alahdal AM, Radwan MF, El-Araby ME. Design, Synthesis and Antiproliferative Activities of Oxidative Stress Inducers Based on 2-styryl-3,5-dihydro-4H-imidazol-4-one Scaffold. Chemical & Pharmaceutical Bulletin. PMID 30047515 DOI: 10.1248/Cpb.C18-00398  0.484
2018 Mohamed MS, Mansour YE, Amin HK, El-Araby ME. Molecular modelling insights into a physiologically favourable approach to eicosanoid biosynthesis inhibition through novel thieno[2,3-b]pyridine derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. 33: 755-767. PMID 29651867 DOI: 10.1080/14756366.2018.1457657  0.466
2017 Alasmary FAS, Alnahdi FS, Ben Bacha A, El-Araby AM, Moubayed N, Alafeefy AM, El-Araby ME. New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase. Journal of Enzyme Inhibition and Medicinal Chemistry. 32: 1143-1151. PMID 28856929 DOI: 10.1080/14756366.2017.1363743  0.465
2017 El-Araby ME, Omar AM, Khayat MT, Assiri HA, Al-Abd AM. Molecular Mimics of Classic P-Glycoprotein Inhibitors as Multidrug Resistance Suppressors and Their Synergistic Effect on Paclitaxel. Plos One. 12: e0168938. PMID 28068430 DOI: 10.1371/Journal.Pone.0168938  0.406
2016 Omar AM, Mahran MA, Ghatge MS, Bamane FH, Ahmed MH, El-Araby ME, Abdulmalik O, Safo MK. Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin. Molecules (Basel, Switzerland). 21. PMID 27529207 DOI: 10.3390/Molecules21081057  0.473
2015 Omar AM, Mahran MA, Ghatge MS, Chowdhury N, Bamane FHA, El-Araby ME, Abdulmalik O, Safo MK. Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents Organic and Biomolecular Chemistry. 13: 6353-6370. PMID 25974708 DOI: 10.1039/C5Ob00367A  0.47
2013 Elsayed MS, El-Araby ME, Serya RA, El-Khatib AH, Linscheid MW, Abouzid KA. Structure-based design and synthesis of novel pseudosaccharine derivatives as antiproliferative agents and kinase inhibitors. European Journal of Medicinal Chemistry. 61: 122-31. PMID 23063746 DOI: 10.1016/J.Ejmech.2012.09.039  0.482
2012 El-Araby M, Omar A, Hassanein HH, El-Helby AG, Abdel-Rahman AA. Design, synthesis and in vivo anti-inflammatory activities of 2,4-diaryl-5-4H-imidazolone derivatives. Molecules (Basel, Switzerland). 17: 12262-75. PMID 23079497 DOI: 10.3390/Molecules171012262  0.41
2012 Elsayed MS, El-Araby ME, Serya RT, Abouzid KA. Virtual screening and synthesis of new chemical scaffolds as VEGFR-2 kinase inhibitors. Arzneimittel-Forschung. 62: 554-60. PMID 23023518 DOI: 10.1055/S-0032-1323759  0.437
2012 El Ella DAAE, Saleh KA, Hassan M, Hamdy N, El-Araby ME, Abouzid KAM. Synthesis and anti-proliferative activity of substituted- anilinoquinazolines and its relation to EGFR inhibition Arzneimittel-Forschung/Drug Research. 62: 360-366. PMID 22723174 DOI: 10.1055/S-0032-1312601  0.527
2010 Abouzid KAM, Khalil NA, Ahmed EM, El-Latif HAA, El-Araby ME. Structure-based molecular design, synthesis, and in vivo anti-inflammatory activity of pyridazinone derivatives as nonclassic COX-2 inhibitors Medicinal Chemistry Research. 19: 629-642. DOI: 10.1007/S00044-009-9218-4  0.421
2004 El-Araby M, Pottorf RS, Player MR. Synthesis of a 2, 4, 8-trisubstituted pyrimidino[5, 4-d]pyrimidine library via sequential SNAr reactions on solid-phase. Combinatorial Chemistry & High Throughput Screening. 7: 413-421. PMID 15320708 DOI: 10.2174/1386207043328571  0.322
2004 El-Araby ME, Bernacki RJ, Makara GM, Pera PJ, Anderson WK. Synthesis, molecular modeling, and evaluation of nonphenolic indole analogs of mycophenolic acid. Bioorganic & Medicinal Chemistry. 12: 2867-79. PMID 15142547 DOI: 10.1016/J.Bmc.2004.03.048  0.462
Show low-probability matches.